On April 9, 2015, Novitas Solutions, Inc., the Medicare Administrative Contractor for Jurisdiction L [includes states: DC, PA, NJ, MD, DE] and Jurisdiction H [includes states: CO, OK, NM, MS, LA, AR, TX], implemented a coverage policy which includes use of AMNIOEXCEL® membrane. The Novitas policy [ID # L27459] may be found at on CMS.gov website. Novitas is one of the largest Medicare Administrative Contractors, administering claims processing and payment, as well as developing coverage policies which guide clinicians on which products and services are eligible for payment under the Medicare program.
The Novitas policy allows clinicians to choose AMNIOEXCEL® membrane for chronic wounds of the lower extremity including Diabetic Foot Ulcers, Venous Leg Ulcers, wounds resulting from abscess, trauma or injury which have endured for at least four weeks.
As part of the coverage policy, Novitas does recognize the importance of off-loading for diabetic foot ulcers, which must be documented in the medical record. Our product portfolio includes off-loading products such as TCC-EZ®, MedE-Kast® and MedE-Kast® Ultra.
DermaSciences is extremely pleased that AMNIOEXCEL® membrane will now be an available treatment under the Novitas coverage policy.
Should you have questions concerning AMNIOEXCEL® membrane, please refer to the product information at www.dermasciences.com/amnioexcel and your local DermaSciences representative.